News | Treatment Planning | January 30, 2018

Treatment planning system will be employed at U.K. hospitals for 3-D-CRT, IMRT, VMAT and other adaptive planning applications

RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital

January 30, 2018 — Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected following a thorough evaluation of all potential treatment planning systems on the market.

The Imperial College Healthcare NHS Trust operates five hospitals in London, plus a range of community health services. Its radiation therapy services are provided at Charing Cross Hospital and Hammersmith Hospital. RayStation will replace two different treatment planning systems currently in use at the hospitals.

The two hospitals will use RayStation for all radiation therapy treatment planning activities, as well as all pre-treatment virtual simulation. RayStation will replace the hospitals’ current standalone system for virtual simulation. The purchase comprises a broad range of functionality, including three-dimensional conformal radiation therapy (3-D-CRT), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), multi-criteria optimization (MCO), automated breast planning and adaptive planning.

RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines features such as MCO tools with full support for 4-D adaptive radiation therapy. It also includes functionality such as RaySearch’s algorithms for IMRT and VMAT optimization, and highly accurate dose engines for photon, electron, proton and carbon ion therapy.

For more information: www.raysearchlabs.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now